International Journal of Oncology

FATAL ATTRACTION - THE FOS-JUN AFFAIR WITH NUCLEAR RECEPTORS
pp. 5-8(4)
Author: SASSONECORSI, P

STRUCTURE, BIOLOGY AND POSSIBLE CLINICAL-APPLICATIONS OF CARCINOMA-ASSOCIATED MUCINS
pp. 9-16(8)
Authors: TAYLORPAPADIMITRIOU, J; GENDLER, SJ

VASOACTIVE-INTESTINAL-PEPTIDE (VIP) MODULATES THE GROWTH FRACTION OF EPITHELIAL SKIN CELLS
pp. 17-24(8)
Authors: WOLLINA, U; BONNEKOH, B; MAHRLE, G

DIFFERENTIATION OF GLIOMA-CELLS BY A PDGF-ANTAGONIST
pp. 25-29(5)
Authors: KURATSU, JI; MIHARA, Y; TAKAKI, S; USHIO, Y

COINDUCTION OF HSP27 PHOSPHORYLATION AND DRUG-RESISTANCE IN CHINESE-HAMSTER CELLS
pp. 31-36(6)
Authors: HUOT, J; ROY, G; LAMBERT, H; LANDRY, J

FUNCTIONAL IMPLICATIONS OF THE GROWTH-SUPPRESSOR ONCOPROTEIN P53
pp. 37-45(9)
Author: MONTENARH, M

ALVEOLAR RHABDOMYOSARCOMA - PRIMARY AND RECURRENT METASTATIC TUMOR HAS CHROMOSOMAL TRANSLOCATION T(2-13)(Q37-Q14), AMPLIFIED N-MYC AND IS TUMORIGENIC IN NUDE-MICE
pp. 47-51(5)
Authors: DIAS, P; KUMAR, P; MARSDEN, HB; GATTAMANENI, HR; HEIGHWAY, J; KUMAR, S

RAS P21 EXPRESSION IN NEUROBLASTOMAS AND GANGLIO-NEUROBLASTOMAS - CORRELATION WITH PATIENTS PROGNOSIS
pp. 53-58(6)
Authors: SPANDIDOS, DA; ARVANITIS, D; FIELD, JK

REVERSIBLE DISSOCIATION OF A TUMOR-CELL SURFACE PROTEASE-INHIBITOR COMPLEX
pp. 59-61(3)
Authors: STEVEN, FS; GRIFFIN, MM; BLAKEY, DC

LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A MULTIMODAL THERAPY INCLUDING ALTERNATING NEOADJUVANT CHEMOTHERAPY, SURGERY AND RADIOTHERAPY
pp. 63-68(6)
Authors: GASPARINI, G; BERLANDA, G; RICCI, G; PANIZZONI, GA; GERMANI, B; BOLZICCO, GP; POZZA, F

OVEREXPRESSION OF C-FOS AND C-ERBB1 ENCODED PROTEINS IN SQUAMOUS-CELL CARCINOMAS OF THE LUNG OF SMOKERS
pp. 69-71(3)
Authors: VOLM, M; EFFERTH, T; MATTERN, J; WODRICH, W

ACTIVATION OF THE HUMAN MULTIDRUG RESISTANCE-1 (MDR1) GENE PROMOTER IN RESPONSE TO INHIBITORS OF DNA TOPOISOMERASES
pp. 73-77(5)
Authors: KOHNO, K; SATO, SI; UCHIUMI, T; TAKANO, H; TANIMURA, H; MIYAZAKI, M; MATSUO, KI; HIDAKA, K; KUWANO, M

MULTIPLE PHENOTYPES INDUCED BY MUTANT HA-RAS IN THYROID EPITHELIAL-CELLS - CORRELATION WITH LEVEL OF EXPRESSION
pp. 79-92(14)
Authors: BURNS, JS; SHAW, J; WILLIAMS, ED; WYNFORDTHOMAS, D

CIRCUMVENTION OF CISPLATIN RESISTANCE IN H-RAS TRANSFORMED-NIH/3T3 CELLS BY SUPPRESSOR MUTANT OF H-RAS
pp. 93-96(4)
Authors: SHINOHARA, N; OGISO, Y; KUZUMAKI, N; MULLAUER, L; KATABAMI, M; TOGASHI, M; KOYANAGI, T

GROWTH-INHIBITION OF HT29 CELLS EXPOSED TO N-METHYLFORMAMIDE CORRELATES WITH ALTERED EXPRESSION OF ALPHA-6/BETA-4 INTEGRIN
pp. 97-105(9)
Authors: DELBUFALO, D; ZUPI, G; DAGNANO, I; FALCIONI, R; MARANGOLO, M; SACCHI, A

ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF A NOVEL 21-KDA PROTEIN ASSOCIATED WITH THE CLINICAL COURSE OF PATIENTS WITH UROGENITAL TUMORS
pp. 107-112(6)
Authors: SHALITIN, C; EPELBAUM, R; MOSKOVITZ, B; SEGAL, R; VALANSI, C; MEKORI, T; LERNER, M